age
Item
at least 60 years old
boolean
C0001779 (UMLS CUI [1])
systolic blood pressure
Item
sitting systolic blood pressure on masked placebo, during run-in phase of 160 to 219 mmhg, with a sitting diastolic blood pressure below 95 mmhg and a standing systolic blood pressure of at least 140 mmhg
boolean
C0871470 (UMLS CUI [1])
informed consent
Item
informed consent must be obtained
boolean
C0021430 (UMLS CUI [1])
secondary hypertension
Item
systolic hypertension is secondary to a disorder that needed specific medical or surgical treatment
boolean
C0155616 (UMLS CUI [1])
retinal haemorrhage or papilloedema
Item
retinal haemorrhage or papilloedema
boolean
C0035317 (UMLS CUI [1])
C0030353 (UMLS CUI [2])
congestive heart failure
Item
congestive heart failure
boolean
C0018802 (UMLS CUI [1])
dissecting aortic aneurysm
Item
dissecting aortic aneurysm
boolean
C0012736 (UMLS CUI [1])
serum creatinine concentration
Item
serum creatinine concentration at presentation of 180µmol/l or more
boolean
C0600061 (UMLS CUI [1])
history of severe nose bleeds
Item
history of severe nose bleeds
boolean
C0014591 (UMLS CUI [1])
stroke or myocardial infarction
Item
stroke or myocardial infarction in the year before the study
boolean
C4039739 (UMLS CUI [1])
C1275835 (UMLS CUI [2])
dementia
Item
dementia
boolean
C0497327 (UMLS CUI [1])
substance abuse
Item
substance abuse
boolean
C0740858 (UMLS CUI [1])
prohibited sitting or standing position
Item
any disorder prohibiting a sitting or standing position
boolean
C0424866 (UMLS CUI [1,1])
C0277814 (UMLS CUI [1,2])
C0231472 (UMLS CUI [1,3])
severe comorbidity
Item
any severe concomitant cardiovascular or non-cardiovascular disease
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])